Skip to main content
Clinical Trials/NCT03698708
NCT03698708CompletedNot Applicable

Longitudinal Test of Adherence & Control in Kids New to Type 1 Diabetes & 5-9 Years Old

University of Kansas Medical Center2 sites in 1 country37 target enrollmentStarted: January 20, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
37
Locations
2
Primary Endpoint
Problem Areas in Diabetes Survey - Parent Revised (PAID-PR)

Study Overview

Brief Summary

The purpose of this study is to evaluate a new intervention (CARES: Cognitive Adaptations to Reduce Emotional Stress Associated with Type 1 Diabetes) designed to reduce caregiver depressive symptoms in families of children with T1D. This is a pilot in which all enrolled parents/caregivers will be placed in the intervention group to assess initial pre- to post-treatment impact of the intervention on parent/caregiver depression, distress, and diabetes-related outcomes (e.g., glycemic control).

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
5 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Parent/primary caregiver of a child diagnosed with T1D between 5-12 years old
  • Parent/caregiver elevated depression symptoms on the CESD-R (score ≥ 16 at time of screening)
  • Child with T1D receiving intensive insulin regimen by multiple dose injections (MDI) or continuous subcutaneous insulin infusion (pump)

Exclusion Criteria

  • Child with T1D currently in foster care or not living with legal guardian
  • Child with evidence of type 2 diabetes or monogenic diabetes
  • Child with a co-morbid chronic illness (e.g., renal disease) that requires ongoing care beyond T1D
  • Children who are chronically using medications that may impact glycemic control (i.e., systemic steroids)
  • Parents/caregivers who do not speak English (currently there is no way to recruit non-English speaking families because the study questionnaires are only available in English)

Outcomes

Primary Outcomes

Problem Areas in Diabetes Survey - Parent Revised (PAID-PR)

Time Frame: absolute value Post-treatment (week 24)

Problem Areas in Diabetes Survey - Parent Revised (PAID-PR); Parents' perceptions of diabetes-related distress, which can encompass fear, sadness, grief, anger, burn-out, and guilt. Higher scores reflect greater perceived distress (range: 0-72)

Center for Epidemiologic Studies - Depression Scale Revised (CESD-R)

Time Frame: absolute value at Post-treatment (week 24)

Center for Epidemiologic Studies - Depression Scale Revised (CESD-R); measure of parental depressive symptoms. Used as a secondary marker of improvement. Higher scores reflect greater occurrence of depressive symptoms (range: 0-60)

Secondary Outcomes

  • Diabetes Family Conflict Scale (DFCS)(absolute value Post-treatment (week 24))
  • Hypoglycemia Fear Survey (HFS-P)(absolute value Post-treatment (week 24))
  • Hemoglobin A1c (HbA1c)(absolute value at Post-treatment (week 24))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials